Amgen, Astra Drug Duo Boosts Survival for Deadly Lung Cancer
Doctors combined powerful medicines from Amgen Inc. and AstraZeneca Plc and found they allowed patients with an aggressive form of lung cancer to live eight months longer.
By Ashleigh Furlong · Bloomberg
Doctors combined powerful medicines from Amgen Inc. and AstraZeneca Plc and found they allowed patients with an aggressive form of lung cancer to live eight months longer.